Welcome to our dedicated page for Xebra Brands news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on Xebra Brands stock.
Xebra Brands Ltd. (XBRAF) maintains its position as Mexico's pioneering fully licensed cannabis company, specializing in COFEPRIS-approved CBD products and regulated cultivation operations. This news hub provides investors with essential updates on regulatory milestones, product developments, and strategic initiatives shaping the company's trajectory in the evolving cannabis sector.
Access real-time updates on XBRAF's compliance achievements, manufacturing partnerships, and market expansion efforts. Our curated news collection covers critical developments including new product authorizations, supply chain enhancements, and regulatory strategy adjustments specific to Mexico's cannabis framework.
Key coverage areas include COFEPRIS approval updates, wellness product launches, cultivation license expansions, and strategic collaborations with industry partners. Each update is verified for regulatory accuracy and operational relevance to maintain investor confidence in this complex market environment.
Bookmark this page for streamlined access to Xebra Brands' official communications and third-party analyses. Monitor the company's progress in navigating Mexico's cannabis regulations while maintaining its first-mover advantage in authorized CBD product distribution.
Xebra Brands Ltd. (CSE:XBRA) announced a delay in its previously announced 1:10 share consolidation due to regulatory requirements from the Canadian Securities Exchange. The delay is attributed to an existing cease trade order (CTO) which must be revoked before proceeding with the consolidation.
The consolidation, initially announced on August 15 and September 12, 2025, would have consolidated every ten pre-consolidation common shares into one post-consolidation share. The company is actively working to complete the necessary regulatory requirements and filings to achieve CTO revocation and will provide updates as they become available.
Xebra Brands (CSE:XBRA) announced the implementation of its previously disclosed 1-for-10 share consolidation, effective September 19, 2025. The consolidation will reduce outstanding shares to approximately 8,065,442. However, trading remains suspended due to a cease trade order (CTO) issued by the British Columbia Securities Commission on September 3, 2025.
The CTO resulted from Xebra's failure to file required financial documents, including annual statements for the year ended February 28, 2025, and interim filings for Q1 2025. The company will maintain its current name and trading symbol, with new CUSIP (98402E305) and ISIN (CA98402E3059) numbers assigned. Trading will remain halted until the company files the required documents and the CTO is lifted.
Xebra Brands (XBRAF) announced it will not meet the deadline to file its annual financial statements and related documents for the year ended February 28, 2025. The British Columbia Securities Commission (BCSC) is expected to issue a cease trade order (CTO), replacing the previous management cease trade order from July 2, 2024.
The company faced delays due to liquidity constraints and management changes. A previously announced C$110,000 loan agreement to complete the filings has been terminated. Trading on the Canadian Securities Exchange will be suspended until required documents are filed. Additionally, Xebra's listing has been downgraded from OTCQB to OTC Pink Open Market.
Xebra Brands (CSE:XBRA) has announced a significant 10:1 share consolidation of its common shares, which will reduce the outstanding shares from 84,144,855 to approximately 8,414,486. The consolidation is expected to take effect around August 28, 2025, subject to regulatory approvals.
The company also provided an update on its previously announced Management Cease Trade Order (MCTO), confirming delays in filing its annual financial statements for the year ended February 28, 2025. Xebra attributes these delays to liquidity constraints and recent management changes, expecting to file the required documents by August 29, 2025.
Xebra Brands (OTC:XBRAF) has provided an update regarding its previously announced Management Cease Trade Order (MCTO). The company failed to file its required Annual Financial Filings for the year ended February 28, 2025, by the June 30, 2025 deadline due to liquidity constraints and recent management changes.
The company expects to complete and file the required documents by August 29, 2025. Until then, Xebra will issue bi-weekly default status reports and confirms no material business developments have occurred since the last disclosure.
Xebra Brands (OTCQB:XBRAF), an international cannabis company, has provided an update regarding its previously announced Management Cease Trade Order (MCTO). The company failed to file its required Annual Financial Filings for the year ended February 28, 2025 by the June 30, 2025 deadline.
The delay is attributed to liquidity constraints and recent management changes. Xebra expects to complete and file the required documents by August 29, 2025. During this period, the company will issue bi-weekly default status reports and confirms no undisclosed material business developments have occurred.
Xebra Brands (OTCQB:XBRAF) has announced three significant developments: First, the company has terminated its non-binding Letter of Intent to acquire BSK Holdings Inc., originally announced on April 24th, 2025, after determining it wasn't in the company's best interest following due diligence.
Despite the terminated acquisition, Xebra will maintain its partnership with BSK to launch its ELEMENTS™ CBD product line in the United States. Additionally, the company has disclosed a delay in filing its annual financial statements for the year ended February 28, 2025, resulting in a voluntary Management Cease Trade Order (MCTO).
Lastly, Xebra has secured a C$110,000 loan from an existing shareholder at 10% annual interest, maturing in one year, to support working capital needs and complete the delayed annual audit.
Xebra Brands Ltd. (XBRAF) has announced significant progress in its U.S. commercialization strategy, particularly regarding the upcoming launch of its ELEMENTS™ CBD product line scheduled for Summer 2025. Through its partnership with NF Skin and RT Fulfillment, the company has completed several crucial milestones, including:
- Finalization of product formulations including tinctures, gummies, topicals, and wellness supplements
- Completion of e-commerce planning and FDA compliance activities
- Development of branded packaging and marketing assets
- Integration with RT Fulfillment's logistics infrastructure for nationwide distribution
The initiative represents Xebra's strategic move to diversify its portfolio and generate revenue from the growing U.S. CBD market through both e-commerce and retail channels.
FAQ
What is the current stock price of Xebra Brands (XBRAF)?
What is the market cap of Xebra Brands (XBRAF)?
